2Zanotti KM, Hart WR, Kennedy AW, et al. Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors. Int J Gynecol Pathol,1999,18(3) :247.
3Hu J, Khanna MM, Surti U. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet, 2002,139(1) :18.
4Kiziridou AD,Toliou T, Stefanou D, et al. u-PA expression in benign, borderline and malignant ovarian tumors. Anticancer Res,2002,22(2A) :958.
5Deavers MT, Gershenson DM,Torrolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential :a study of 99 advanced stage cases. Am J Surg Pathol,2002,26(9) :1129.
6Gotlieb WH, Soriano D, Achiron R, et al. CA125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol,2000,183 (3) :541.
8Camatte S, Morice P, Atallah D, et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor:an analysis of a series of 42 lymphadenectomies. J Am Coll Surg,2002,195(3) :332.
5Chambers JT. Borderline ovarian tumors: a review of treatment.Yole J Biol Med,1989,62(3):351.
6Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer, 1998, 83(10): 2157.
7Tazelear HD, Bostwick DG, Ballon SC, et al. Conservative treatment of borderline ovarian tumors, Obstet Gynecol, 1985,66(3):417.
8Trope C, kaem, Vergote IB. Are borderline tumors of the ovary overtreated both surgically systemically:a review of four prospective randomixed trials including 253 patients with borderline tumors. Gynecol Oncol, 1993, 51(2): 236.
9Hart WR.Borderline epthelial tumors of the ovary.Mod Partol,2005,18 Suppl 2:S33-S55.
10Allison KH,Swisher EM,Kerkering KM,et al.Defining an appmpriale threshold for the diagnosis of serous borderline tumor of the ovary:when is a full slaging prnocedure unneeessary? Int J Gynecol Pathol,2008,27(1):10-17.
